Anxiety Drug in Short Supply

February 11, 2019

Several drug manufacturers are experiencing a shortage of buspirone, an oral medication used to treat anxiety, according to the US Food and Drug Administration (FDA).

The FDA’s Drug Shortages database shows the 5 manufacturers are all experiencing some level of shortage, with increased demand the most commonly cited reason.

The companies expect the shortage to be resolved between February and April, according to the FDA database.

Psych Congress cochair Rakesh Jain, MD, MPH, said the medication is “fairly infrequently used,” and “the total number of people who will be affected by this temporary shortage is going to be relatively modest.” 

According to a report in The New York Times, the main reason for the shortage may be interrupted production at a Mylan Pharmaceuticals plant in Morgantown, West Virginia. The facility produced about a third of the supply of the drug in the US, but the FDA found it was dirty and that the company failed to follow quality control procedures, the Times reported.

—Terri Airov

Psych Topics: